Homologous unequal cross-over within the human CYP2A gene cluster as a mechanism for the deletion of the entire CYP2A6 gene associated with the poor metabolizer phenotype

被引:53
作者
Nunoya, K
Yokoi, T
Takahashi, Y
Kimura, K
Kinoshita, M
Kamataki, T
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Sapporo, Hokkaido 0600812, Japan
[2] Sumitomo Pharmaceut Co Ltd, Clin Res & Dev Div, Osaka 5410045, Japan
[3] Otsuka Pharmaceut Co Ltd, Div Diagnost, Tokushima 7710130, Japan
关键词
coumarin; genetic polymorphism; gene analysis; pharmacogenetics; RFLP;
D O I
10.1093/oxfordjournals.jbchem.a022464
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To clarify the molecular mechanisms involved in the generation of the CYP2A6 gene deletion (E-type variant), we analyzed the CYP2A7 gene, which is located in the 5'-flanking region of the GYP2A6 gene, from individuals with the E-type variant and compared it wit;lr the sequences of wild type CYP2A7 and CYP2A6 genes. The 3'-downstream sequence (up to 324 bp from the SacI site in exon 9) of the CYP2A7 gene of the E-type variant is identical to that of the wild CYP2A7 gene. However, the 3'-downstream sequence (starting from 325 bp from the SacI site in exon 9) of the CYP2A7 gene of the E-type variant is identical to that of the wild CYP2A6 gene, indicating that the 3'-downstream region of CYP2A7 and the 3'-downstream region of CYP2A6 linked directly eliminating the whole CYP2A6 gene, PCR analysis using primers specific to the CYP2A7 gene and the CYP2A6 and CYP2A7 genes confirmed that all DNA samples obtained from 7 individuals carrying the E-type variant possessed the same break points. These results indicate that the breakpoint of the CYP2A6 gene deletion lies in the 3'-downstream region of the CYP2A7 and CYP2A6 genes.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 21 条
  • [1] [Anonymous], 1989, Molecular Cloning: A Laboratory Manual
  • [2] 5 OF 12 FORMS OF VACCINIA VIRUS-EXPRESSED HUMAN HEPATIC CYTOCHROME-P450 METABOLICALLY ACTIVATE AFLATOXIN-B1
    AOYAMA, T
    YAMANO, S
    GUZELIAN, PS
    GELBOIN, HV
    GONZALEZ, FJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4790 - 4793
  • [3] COMPARISON OF A NOVEL THIN-LAYER CHROMATOGRAPHIC-FLUORESCENCE DETECTION METHOD WITH A SPECTROFLUOROMETRIC METHOD FOR THE DETERMINATION OF 7-HYDROXYCOUMARIN IN HUMAN URINE
    CHOLERTON, S
    IDLE, ME
    VAS, A
    GONZALEZ, FJ
    IDLE, JR
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 575 (02): : 325 - 330
  • [4] A TOBACCO SMOKE-DERIVED NITROSAMINE, 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, IS ACTIVATED BY MULTIPLE HUMAN CYTOCHROME P450S INCLUDING THE POLYMORPHIC HUMAN CYTOCHROME P4502D6
    CRESPI, CL
    PENMAN, BW
    GELBOIN, HV
    GONZALEZ, FJ
    [J]. CARCINOGENESIS, 1991, 12 (07) : 1197 - 1201
  • [5] HUMAN CYTOCHROME P450IIA3 - CDNA SEQUENCE, ROLE OF THE ENZYME IN THE METABOLIC-ACTIVATION OF PROMUTAGENS, COMPARISON TO NITROSAMINE ACTIVATION BY HUMAN CYTOCHROME P450IIE1
    CRESPI, CL
    PENMAN, BW
    LEAKEY, JAE
    ARLOTTO, MP
    STARK, A
    PARKINSON, A
    TURNER, T
    STEIMEL, DT
    RUDO, K
    DAVIES, RL
    LANGENBACH, R
    [J]. CARCINOGENESIS, 1990, 11 (08) : 1293 - 1300
  • [6] FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
  • [7] GAEDIGK A, 1991, AM J HUM GENET, V48, P943
  • [8] Hoffman SMG, 1995, J MOL EVOL, V41, P894
  • [9] ISCAN M, 1994, EUR J CLIN PHARMACOL, V47, P315
  • [10] ISOLATION AND CHARACTERIZATION OF A CYTOCHROME-P450 OF THE IIA SUBFAMILY FROM HUMAN LIVER-MICROSOMES
    MAURICE, M
    EMILIANI, S
    DALETBELUCHE, I
    DERANCOURT, J
    LANGE, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 200 (02): : 511 - 517